Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 5 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 5

From: Role of [18F] FDG PET-CT in detection of COVID-19 vaccine-associated hypermetabolic lymphadenopathy (VAHL) in lymphoma patients: with serologic testing correlation

Fig. 5

A 45-year-old male patient with NHL, treated with anti-cd20 antibody rituximab 25 months prior to vaccination. The most recent PET/CT showed enlarged amalgamated left axillary LNs. Further clinical data revealed that he got his 2nd dose of Pfizer-BioNTech vaccine 9 days before the PET-CT study. So, these findings were ascribed to recent vaccination. A Axial and C coronal CECT images revealed enlarged amalgamated left axillary LNs about 8 cm. B Axial and D coronal PET/CT images revealed FDG-avid left axillary LNs of 17 SUVmax

Back to article page